Oruka Therapeutics, Inc. · NASDAQ:ORKA
BlackRock, Inc. reported a 5.30% stake in Oruka Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 5.30% stake in Oruka Therapeutics, Inc., 1,988,880 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 1,988,880
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.30% | 1,988,880 |
Source
Related
- Oruka Therapeutics, Inc.
- BlackRock, Inc.
- Oruka Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026